Skip to main content

Table 1 Demographic, clinical and immunological characteristics of the patients with SSc (n = 134, 100%)

From: Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis

Variable Result
Age at SSc onset (years) 38.5 (± 15.7)
Age at NVC (years) 54.7 (± 14.4)
Cutaneous subsets, dcSSc/lcSSc/ssSSc 28 (20.9)/88 (65.7)/18 (13.4)
Time elapsed from first symptom to NVC (years) 16.0 (± 12.6)
Time elapsed from first non-RP symptom to NVC (years) 10.9 (± 9.9)
2013 ACR/EULAR SSc classification criteria fulfilment 121 (90.2)
ACA/ATA/anti-RNA pol III/anti-PM/Scl 49 (36.6)/31 (23.1)/14 (10.4)/11 (8.2)
Raynaud’s phenomenon 132 (98.5)
Telangiectasias 97 (72.4)
Digital ulcers 62 (46.3)
Calcinosis 29 (21.6)
Scleroderma renal crisis 2 (1.5)
Interstitial lung disease 58 (43.3)
Pulmonary arterial hypertension 11 (8.2)
Cardiac involvement 103 (76.9)
Musculoskeletal disease 40 (29.9)
Gastrointestinal involvement 110 (82.1)
Overlap features 19 (14.1)
  1. Data presented as mean (± standard deviation) for continuous variables and as number (%) for categorical variables
  2. SSc systemic sclerosis, NVC nailfold videocapillaroscopy, dcSSc diffuse cutaneous systemic sclerosis, lcSSc limited cutaneous systemic sclerosis, ssSSc sine scleroderma systemic sclerosis, RP Raynaud’s phenomenon, ACR American College of Rheumatology, EULAR European League Against Rheumatism, ACA anticentromere antibodies, ATA anti-topoisomerase I